Inclusion and Exclusion Criteria

Inclusion criteria:

  • Adults aged ≥ 18 years with a baseline NOSE score ≥30
  • Septal Deflection at baseline visible at naseondoscopy
  • Capacity to provide informed written consent and complete the study questionnaires
  • Participants are willing and able to provide full written informed consent

 Exclusion criteria:

  • Any prior septal surgery
  • Systemic inflammatory disease or the use of any current oral steroid treatment within the past 2 weeks
  • Granulomatosis with polyangiitis
  • Naseondoscopic evidence of unrelated associated pathology e.g. adenoid pad, septal perforation, chronic rhinosinusitis indicated by the prescence of polyposis or pus
  • Any history of intranasal recreational drug use within the past 6 months
  • Breast feeding, pregnancy or intended pregnancy for duration of involvement in trial
  • Bleeding diathesis
  • Therapeutic anticoagulation (Warfarin/NOAC therapy)
  • Clinically significant contraindication to general anaesthesia
  • Patient known to be immuno-compromised
  • External bony deformity likely to make a substantial contribution to the nasal obstruction